{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:58:45Z","timestamp":1763017125924},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ongoing psychiatric symptoms and substance use are common difficulties experienced by clients enrolled in methadone maintenance treatment (MMT). However, little research to date has evaluated if specific types of current substance use are related to specific types of current psychiatric symptoms. The present study investigated these relationships with a sample of clients enrolled in a low-threshold MMT program (i.e., clients are not expelled if they continue to use substances). Some clients enrolled in low-threshold programs may never achieve complete abstinence from all substances. Thus, understanding the possibly perpetuating relationships between concurrent substance use and psychiatric symptoms is important. Understanding such relationships may aid in developing possible target areas of treatment to reduce substance use and\/or related harms in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Seventy-seven individuals were interviewed regarding methadone usage and current and past substance use. Current psychiatric symptoms were assessed using a modified version of the Psychiatric Diagnostic Screening Questionnaire (PDSQ). Relationships between types of substances used in the past 30 days and the types and number of psychiatric symptoms experienced in the same timeframe were examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The majority of participants (87.0%) reported using alcohol, illicit substances, non-prescribed prescription opioids, or non-prescribed benzodiazepines in the past 30 days and 77.9% of participants reported currently experiencing psychiatric symptoms at levels that would likely warrant diagnosis. Current non-prescribed benzodiazepine use was a predictor for increased severity (i.e., symptom count) of almost all anxiety and mood disorders assessed. Conversely, number and presence of generalized anxiety symptoms and presence of social phobia symptoms predicted current non-prescribed benzodiazepine and alcohol use, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Individuals enrolled in the present low-threshold MMT program experience a wide variety of psychiatric symptoms and continue to use a variety of substances, including opioids. There was a particularly consistent pattern of associations between non-prescribed benzodiazepine use and a variety of psychiatric symptoms (particularly anxiety) suggesting that addressing concurrent illicit benzodiazepine use and anxiety symptoms in MMT clients warrants further clinical attention and research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7517-8-18","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T06:23:14Z","timestamp":1311920594000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients"],"prefix":"10.1186","volume":"8","author":[{"given":"Heather G","family":"Fulton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"MacIsaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry H","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,28]]},"reference":[{"key":"215_CR1","first-page":"75","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"S Darke","year":"1998","unstructured":"Darke S: The effectiveness of methadone maintenance treatment 3: Moderators of treatment outcome. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Edited by: Ward J, Mattick RP, Hall W. 1998, Amsterdam, Netherlands: Harwood Academic Publishers, 75-89."},{"key":"215_CR2","first-page":"86","volume-title":"Methadone Treatment for Opioid Dependence","author":"ML Stitzer","year":"1999","unstructured":"Stitzer ML, Chutuape MA: Other substance use disorders in methadone treatment. Methadone Treatment for Opioid Dependence. Edited by: Strain EC, Stitzer ML. 1999, Baltimore, Maryland: The John Hopkins University Press, 86-117."},{"key":"215_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1360-0443.1998.931516.x","volume":"93","author":"S Magura","year":"1998","unstructured":"Magura S, Nwakeze PC, Demsky S: Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998, 93: 51-60. 10.1046\/j.1360-0443.1998.931516.x.","journal-title":"Addiction"},{"key":"215_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0376-8716(98)00176-8","volume":"55","author":"AR Morral","year":"1999","unstructured":"Morral AR, Belding MA, Iguchi MY: Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug Alcohol Depend. 1999, 55: 25-33. 10.1016\/S0376-8716(98)00176-8.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR5","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1001\/jama.2008.648","volume":"300","author":"HD Kleber","year":"2008","unstructured":"Kleber HD: Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. J Am Med Assoc. 2008, 300: 2303-2305. 10.1001\/jama.2008.648.","journal-title":"J Am Med Assoc"},{"key":"215_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/archpsyc.1983.04390010030004","volume":"40","author":"AT McLellan","year":"1983","unstructured":"McLellan AT, Luborsky L, Woody GE: Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Arch Gen Psychiatry. 1983, 40: 620-625.","journal-title":"Arch Gen Psychiatry"},{"key":"215_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00952998409002657","volume":"10","author":"AT McLellan","year":"1984","unstructured":"McLellan AT, Childress AR, Griffith J: The psychiatrically severe drug abuse patient: Methadone maintenance or therapeutic community?. Am J Drug Alcohol Abuse. 1984, 10: 77-95. 10.3109\/00952998409002657.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"215_CR8","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3390\/ijerph6112822","volume":"6","author":"M Astals","year":"2009","unstructured":"Astals M, Diaz L, Domingo-Salvany A: Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study. Int J Environ Res Public Health. 2009, 6: 2822-2832. 10.3390\/ijerph6112822.","journal-title":"Int J Environ Res Public Health"},{"key":"215_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/0004867010060507","volume":"35","author":"T Callaly","year":"2001","unstructured":"Callaly T, Trauer T, Munro L: Prevalence of psychiatric disorders in a methadone maintenance population. Aust N Z J Psychiat. 2001, 35: 601-605. 10.1080\/0004867010060507.","journal-title":"Aust N Z J Psychiat"},{"key":"215_CR10","first-page":"126","volume":"43","author":"M Gelkopf","year":"2006","unstructured":"Gelkopf M, Weizman T, Melamed Y: Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Isr J Psychiatr Rel. 2006, 43: 126-136.","journal-title":"Isr J Psychiatr Rel"},{"key":"215_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","volume":"54","author":"K Brooner","year":"1997","unstructured":"Brooner K, King VL, Kidorf M: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiat. 1997, 54: 71-80.","journal-title":"Arch Gen Psychiat"},{"key":"215_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","volume":"61","author":"JS Cacciola","year":"2001","unstructured":"Cacciola JS, Alterman AI, Rutherford MJ: The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001, 61: 271-280. 10.1016\/S0376-8716(00)00148-4.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/10550490903205652","volume":"18","author":"PJ Carpentier","year":"2009","unstructured":"Carpentier PJ, Krabbe PF, van Gogh MT: Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009, 18: 470-480. 10.3109\/10550490903205652.","journal-title":"Am J Addict"},{"key":"215_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0376-8716(97)00115-4","volume":"48","author":"PP Pani","year":"1997","unstructured":"Pani PP, Trogu E, Contu P: Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997, 48: 119-126. 10.1016\/S0376-8716(97)00115-4.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0376-8716(91)90031-S","volume":"27","author":"EC Strain","year":"1991","unstructured":"Strain EC, Brooner RK, Bigelow GE: Clustering of multiple substance use and psychiatric diagnoses in opioid addicts. Drug Alcohol Depend. 1991, 27: 126-134.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1521-0391.1996.tb00308.x","volume":"5","author":"SL Batki","year":"1996","unstructured":"Batki SL, Ferrando SJ, Manfredi L: Psychiatric disorders, drug use and medical status in injection drug users with HIV disease. Am J Addict. 1996, 5: 249-258.","journal-title":"Am J Addict"},{"key":"215_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","volume":"142","author":"EJ Khantzian","year":"1985","unstructured":"Khantzian EJ: The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiat. 1985, 142: 1259-1264.","journal-title":"Am J Psychiat"},{"key":"215_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/0893-164X.14.3.243","volume":"14","author":"PJ Conrod","year":"2000","unstructured":"Conrod PJ, Pihl RO, Stewart SH: Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychol Addict Behav. 2000, 14: 243-256.","journal-title":"Psychol Addict Behav"},{"key":"215_CR19","first-page":"2121","volume":"61","author":"LP Longo","year":"2000","unstructured":"Longo LP, Johnson B: Addiction: Part 1. Benzodiazepines- Side effects, abuse risk and alternatives. Am Fam Physician. 2000, 61: 2121-2128.","journal-title":"Am Fam Physician"},{"key":"215_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00007691-200208000-00001","volume":"24","author":"K Wolff","year":"2002","unstructured":"Wolff K: Characterization of methadone overdose: Clinical considerations and the scientific evidence. Ther Drug Monit. 2002, 24: 457-470. 10.1097\/00007691-200208000-00001.","journal-title":"Ther Drug Monit"},{"key":"215_CR21","first-page":"147","volume-title":"Drugs: Dilemmas and Choices","author":"Royal College of Psychiatrists","year":"2000","unstructured":"Royal College of Psychiatrists: Chapter 8. Treatment of Drug Misuse. Drugs: Dilemmas and Choices. 2000, Thornliebank, Glasgow, UK: Bell and Bain Limited, 147-184."},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/070674370204700606","volume":"47","author":"SR Gross","year":"2002","unstructured":"Gross SR, Barrett SP, Shetowsky JS: Ecstasy and drug consumption patterns: A Canadian rave population study. Can J Psychiat. 2002, 47: 546-551.","journal-title":"Can J Psychiat"},{"key":"215_CR23","volume-title":"The Psychiatric Diagnostic Screening Questionnaire","author":"M Zimmerman","year":"2002","unstructured":"Zimmerman M: The Psychiatric Diagnostic Screening Questionnaire. 2002, Los Angeles, California: Western Psychological Services"},{"key":"215_CR24","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1995","unstructured":"American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 1995, Washington, DC, Author, Fourth edition.","edition":"Fourth"},{"key":"215_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0740-5472(03)00207-1","volume":"26","author":"M Zimmerman","year":"2004","unstructured":"Zimmerman M, Sheeran T, Chelminski I: Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat. 2004, 26: 181-188. 10.1016\/S0740-5472(03)00207-1.","journal-title":"J Subst Abuse Treat"},{"key":"215_CR26","volume-title":"Discovering Statistics Using SPSS","author":"A Field","year":"2009","unstructured":"Field A: Discovering Statistics Using SPSS. 2009, London, UK: Sage Publications Limited, Third edition.","edition":"Third"},{"key":"215_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/hup.766","volume":"21","author":"SP Barrett","year":"2006","unstructured":"Barrett SP, Darredeau C, Pihl RO: Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharm Clin. 2006, 21: 255-263. 10.1002\/hup.766.","journal-title":"Hum Psychopharm Clin"},{"key":"215_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1037\/0022-006X.60.6.835","volume":"60","author":"TA Brown","year":"1992","unstructured":"Brown TA, Barlow DH: Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. J Consult Clin Psych. 1992, 60: 835-844.","journal-title":"J Consult Clin Psych"},{"key":"215_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1891\/jcop.2005.19.3.261","volume":"19","author":"PJ Conrod","year":"2005","unstructured":"Conrod PJ, Stewart SH: Cognitive-behavioral treatments for comorbid substance use and psychiatric disorders: Strengths, limitations and future directions. J Cogn Psychother. 2005, 19: 261-284. 10.1891\/jcop.2005.19.3.261.","journal-title":"J Cogn Psychother"},{"key":"215_CR30","first-page":"141","volume-title":"Methadone Treatment for Opioid Dependence","author":"VL King","year":"1999","unstructured":"King VL, Brooner RK: Assessment and treatment of comorbid psychiatric disorders. Methadone Treatment for Opioid Dependence. Edited by: Strain EC, Stitzer ML. 1999, Baltimore, Maryland: The John Hopkins University Press, 141-165."},{"key":"215_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/0033-2909.109.3.524","volume":"109","author":"J Tzelgov","year":"1991","unstructured":"Tzelgov J, Henik A: Suppression situations in psychological research: Definitions, implications, and applications. Psych Bull. 1991, 109: 524-536.","journal-title":"Psych Bull"},{"key":"215_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10550880802122620","volume":"27","author":"B Brands","year":"2008","unstructured":"Brands B, Blake J, Marsh DC: Impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008, 27: 37-48.","journal-title":"J Addict Dis"},{"key":"215_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0376-8716(93)90047-T","volume":"34","author":"S Darke","year":"1993","unstructured":"Darke S, Swift W, Hall W: Drug-use, HIV risk-taking behavior and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend. 1993, 34: 67-70. 10.1016\/0376-8716(93)90047-T.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR34","first-page":"419","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"J Ward","year":"1998","unstructured":"Ward J, Mattick RP, Hall W: Psychiatric comorbidity among the opioid dependent. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Edited by: Ward J, Mattick RP, Hall W. 1998, Amsterdam, Netherlands: Harwood Academic Publishers, 419-440."},{"key":"215_CR35","first-page":"111","volume-title":"Clinical Manual of Addiction Psychopharmacology","author":"DA Ciraulo","year":"2005","unstructured":"Ciraulo DA, Ciraulo JA, Sands BF, Knapp CM, Sarid-Segal O: Sedative-hypnotics. Clinical Manual of Addiction Psychopharmacology. Edited by: Kranzler HR, Ciraulo DA. 2005, Arlington, Vermont: American Psychiatric Publishing, 111-1s62."},{"key":"215_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/105504901750160484","volume":"10","author":"MA Posternak","year":"2001","unstructured":"Posternak MA, Mueller TI: Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substances abuse or dependence. Am J Addict. 2001, 10: 48-68. 10.1080\/105504901750160484.","journal-title":"Am J Addict"},{"key":"215_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1381612023396744","volume":"8","author":"HA Westra","year":"2002","unstructured":"Westra HA, Stewart SH: As-needed use of benzodiazepines in managing clinical anxiety: Incidence and implications. Curr Pharm Des. 2002, 8: 59-74. 10.2174\/1381612023396744.","journal-title":"Curr Pharm Des"},{"key":"215_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","volume":"103","author":"SS Martins","year":"2009","unstructured":"Martins SS, Keyes KM, Storr CL: Pathways between nonmedical opioid use\/dependence and psychiatric disorders: Results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend. 2009, 103: 16-24. 10.1016\/j.drugalcdep.2009.01.019.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/schbul\/16.1.123","volume":"1","author":"SM Ridgely","year":"1990","unstructured":"Ridgely SM, Goldman HH, Willenbring M: Barriers to the care of persons with dual diagnoses: Organizational and financial issues. Schizophr Bull. 1990, 1: 123-132.","journal-title":"Schizophr Bull"},{"key":"215_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cpr.2005.05.004","volume":"25","author":"EP Morris","year":"2005","unstructured":"Morris EP, Stewart SH, Ham LS: The relationship between social anxiety disorder and alcohol use disorders: A critical review. Clin Psychol Rev. 2005, 25: 734-760. 10.1016\/j.cpr.2005.05.004.","journal-title":"Clin Psychol Rev"},{"key":"215_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0740-5472(89)90003-2","volume":"6","author":"TA Kosten","year":"1989","unstructured":"Kosten TA, Kosten TR, Rounsaville BJ: Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat. 1989, 6: 163-168. 10.1016\/0740-5472(89)90003-2.","journal-title":"J Subst Abuse Treat"},{"key":"215_CR42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S: Self-report among injecting drug users: A review. Drug Alcohol Depend. 1998, 51: 252-263.","journal-title":"Drug Alcohol Depend"},{"key":"215_CR43","first-page":"239","volume-title":"Methadone Maintenance Treatment and Other Opioid Replacement Therapies","author":"J Ward","year":"1998","unstructured":"Ward J, Mattick RP, Hall W: The use of urinalysis during opioid replacement therapy. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Edited by: Ward J, Mattick RP, Hall W. 1998, Amsterdam, Netherlands: Harwood Academic Publishers, 239-264."},{"key":"215_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1467-842X.2002.tb00185.x","volume":"26","author":"JR Caplehorn","year":"2002","unstructured":"Caplehorn JR, Drummer OH: Fatal methadone toxicity: Signs and circumstances, and the role of benzodiazepines. Aust N Z J Pub Heal. 2002, 26: 358-363. 10.1111\/j.1467-842X.2002.tb00185.x.","journal-title":"Aust N Z J Pub Heal"},{"key":"215_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cbpra.2007.05.003","volume":"15","author":"M Ahmed","year":"2008","unstructured":"Ahmed M, Westra HA, Stewart SH: A self-help handout for benzodiazepine discontinuation using Cognitive Behavioral Therapy. Cogn Behav Pract. 2008, 15: 317-324. 10.1016\/j.cbpra.2007.05.003.","journal-title":"Cogn Behav Pract"},{"key":"215_CR46","first-page":"291","volume-title":"Treatment Resistant Anxiety Disorders","author":"SH Stewart","year":"2010","unstructured":"Stewart SH, O'Connor RM: Treating anxiety disorders in the context of concurrent substance misuse. Treatment Resistant Anxiety Disorders. Edited by: Sookman D, Leahy R. 2010, New York, New York: Routledge, 291-323."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7517-8-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:27:19Z","timestamp":1630510039000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-8-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,28]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1186\/1477-7517-8-18","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,28]]},"assertion":[{"value":"9 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}